Dr. Coughlin is interested in genetics and ethics, inborn errors in metabolism and Pyridoxine-dependent epilepsy.
Areas of Expertise
- Healthcare Ethics Consultant - Certified (HEC-C), Board Certification (2020)
- Certified Genetic Counselor (CGC), Board Certification (2002)
Education, Licensure & Certifications
- 1995-1999 Bachelor of Science in Biology, Geneva College, Beaver Falls, PA
- 1999-2001 Master of Science in Genetic Counseling, Arcadia University, Glenside, PA
- 2005-2010 Master of Bioethics, University of Pennsylvania School of Medicine, Philadelphia, PA
- 2017-2021 Doctor of Philosophy in Clinical Science, University of Colorado, Aurora, CO
Resumes/CV:
Affiliations
- National Society of Genetic Counselors, Member
- American Board of Genetic Counselors, Diplomate
- Society for Inherited Metabolic Disorders, Member
- American Society for Bioethics + Humanities, Member
- Society for the Study of Inborn Errors of Metabolism, Member
Research
Dr. Coughlin's clinical research is focused on bioethical issues including the intersection of genetics, privacy, and decision-making and pediatric ethical issues such as parental authority and equitable access to medical interventions. His basic science research is primarily focused on inborn errors of metabolism. His laboratory uses animal and cellular models of glutaric aciduria type I (GA I) and pyridoxine-dependent epilepsy (PDE). His team partners with clinicians, scientist and families to investigate the role of biochemistry, current treatment paradigms, and clinical outcomes.